Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial

• Main Authors: Joyce Ojeda (Author), José Luis Arredondo (Author), Perla Salcedo (Author), Mercedes Paredes-Paredes (Author), Martin Dupuy (Author), Celine Petit (Author), Anne Laure Chabanon (Author), Enrique Rivas (Author), Sanjay Gurunathan (Author), Iris De Bruijn (Author), Stephanie Pepin (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Annual vaccination is the most effective way to prevent seasonal influenza. Influenza vaccines in multi-dose vial (MDV) formats can facilitate timely vaccination of large populations by reducing per-dose costs and cold storage requirements compared to single-dose pre-filled syringe (PFS) formats. MD...